[1] |
Flaxel CJ, Yeh S, Lauer AK. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis)[J]. Trans Am Ophthalmol Soc, 2013, 111: 133-144.
|
[2] |
Butler NJ, Moradi A, Salek SS, et al. Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction-positive patients[J]. Am J Ophthalmol, 2017, 179: 179-189.
|
[3] |
Palay DA, Sternberg PJ, Davis J, et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy[J]. Am J Ophthalmol, 1991, 112(3): 250-255.
|
[4] |
Schoenberger SD, Kim SJ, Thorne JE, et al. Diagnosis and treatment of acute retinal necrosis: a report by the american academy of ophthalmology[J]. Ophthalmology, 2017, 124(3): 382-392.
|
[5] |
Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society[J]. Am J Ophthalmol, 1994, 117(5): 663-667.
|
[6] |
Takase H, Okada AA, Goto H, et al. Development and validation of new diagnostic criteria for acute retinal necrosis[J]. Jpn J Ophthalmol, 2015, 59(1): 14-20.
|
[7] |
Neubauer AS, Yu A, Haritoglou C, et al. Peripheral retinal changes in acute retinal necrosis imaged by ultra widefield scanning laser ophthalmoscopy[J]. Acta Ophthalmol Scand, 2005, 83(6): 758-760.
|
[8] |
曾军,唐朝珍,唐罗生,等. 荧光素眼底血管造影在急性视网膜坏死综合征的临床意义[J]. 中国现代医学杂志,2005, 15(10): 1561-1563.
|
[9] |
Suzuki J, Goto H, Minoda H, et al. Analysis of retinal findings of acute retinal necrosis using optical coherence tomography[J]. Ocul Immunol Inflamm, 2006, 14(3): 165-170.
|
[10] |
李娟娟,黎铧,盛智超,等. 急性视网膜坏死光相干断层扫描图像分析[J]. 中国实用眼科杂志,2010,28(3): 247-248.
|
[11] |
Pockar S, Jones NP, Chhabra R, et al. Detection of pre-clinical involvement of the second eye in viral acute retinal necrosis using optical coherence tomography[J]. Ocul Immunol Inflamm, 2020: 1-3.
|
[12] |
Calcagni A, Gibson JM, Styles IB, et al. Multispectral retinal image analysis: a novel non-invasive tool for retinal imaging[J]. Eye (Lond), 2011, 25(12): 1562-1569.
|
[13] |
中国医学装备协会眼科专业委员会. 多光谱眼底分层成像系统的应用标准[J/CD]. 中华眼科医学杂志(电子版),2016,6(4): 187-192.
|
[14] |
Wong RW, Jumper JM, Mcdonald HR, et al. Emerging concepts in the management of acute retinal necrosis[J]. Br J Ophthalmol, 2013, 97(5): 545-552.
|
[15] |
Cochrane TF, Silvestri G, Mcdowell C, et al. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study[J]. Eye, 2012, 26(3): 370-377, 378.
|
[16] |
Sims JL, Yeoh J, Stawell RJ. Acute retinal necrosis: a case series with clinical features and treatment outcomes[J]. Clin Exp Ophthalmol, 2009, 37(5): 473-477.
|
[17] |
Dokey AT, Haug SJ, Mcdonald HR, et al. Acute retinal necrosis secondary to multidrug-resistant herpes simplex virus 2 in an immunocompetent adolescent[J]. Retin Cases Brief Rep, 2014, 8(4): 260-264.
|
[18] |
Tibbetts MD, Shah CP, Young LH, et al. Treatment of acute retinal necrosis[J]. Ophthalmology, 2010, 117(4): 818-824.
|
[19] |
刘蕴佳,杨培增. 急性视网膜坏死综合征的治疗[J]. 国际眼科杂志,2015,15(5): 813-816.
|
[20] |
Soul-Lawton J, Seaber E, On N, et al. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans[J]. Antimicrob Agents Chemother, 1995, 39(12): 2759-2764.
|
[21] |
Fletcher C, Bean B. Evaluation of oral acyclovir therapy[J]. Drug Intell Clin Pharm, 1985, 19(7-8): 518-524.
|
[22] |
Wong R, Pavesio CE, Laidlaw DA, et al. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome[J]. Ophthalmology, 2010, 117(3): 556-560.
|
[23] |
郭立斌,孙鼎,叶俊杰,等. 更昔洛韦玻璃体腔注药术治疗急性视网膜坏死[J]. 中华眼科杂志,2007, 43(7): 631-637.
|
[24] |
Meghpara B, Sulkowski G, Kesen MR, et al. Long-term follow-up of acute retinal necrosis[J]. Retina, 2010, 30(5): 795-800.
|
[25] |
Kishore K, Jain S, Zarbin MA. Intravitreal ganciclovir and dexamethasone as adjunctive therapy in the management of acute retinal necrosis caused by varicella zoster virus[J]. Ophthalmic Surg Lasers Imaging, 2011, 42: e87-e90.
|
[26] |
Munson PD, Nelson ML, Crawford C, et al. Use of intravitreal triamcinolone for the treatment of optic nerve edema in a patient with acute retinal necrosis: case report[J]. Retin Cases Brief Rep, 2015, 9(2): 102-103.
|
[27] |
Choudhury H, Jindal A, Mithal K, et al. Intravitreal triamcinolone acetonide as an adjuvant in the management of acute retinal necrosis[J]. Can J Ophthalmol, 2014, 49(3): 279-282.
|
[28] |
袁菁,胡维琨. 对比两种给药方案治疗急性视网膜坏死综合征患者的效果[J]. 国际眼科杂志,2016,16(7): 1366-1368.
|
[29] |
de Visser L, de Boer JH, Rijkers GT, et al. Cytokines and chemokines involved in acute retinal necrosis[J]. Invest Ophthalmol Vis Sci, 2017, 58(4): 2139-2151.
|
[30] |
Ortega-Evangelio L, Navarrete-Sanchis J, Williams BK, et al. Aflibercept in the management of acute retinal necrosis syndrome-related macular edema[J]. Eur J Ophthalmol, 2018, 28(2): 259-261.
|
[31] |
Sanchez RA, Pinon MR, Mendieta RN. Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis[J]. Arch Soc Esp Oftalmol (Engl Ed), 2019, 94(1): 41-44.
|
[32] |
Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis features, management, and outcomes[J]. Ophthalmology, 2007, 114(4): 756-762.
|
[33] |
Kim DY, Jo J, Joe SG, et al. Clinical feature and visual prognosis of acute retinal necrosis according to the initially involved zone and extent: 10-year experience[J]. Eur J Ophthalmol, 2019, 29(2): 244-250.
|
[34] |
Huang JM, Callanan P, Callanan D, et al. Rate of retinal detachment after early prophylactic vitrectomy for acute retinal necrosis[J]. Ocul Immunol Inflamm, 2018, 26(2): 204-207.
|
[35] |
Luo YH, Duan XC, Chen BH, et al. Efficacy and necessity of prophylactic vitrectomy for acute retinal necrosis syndrome[J]. Int J Ophthalmol, 2012, 5(4): 482-487.
|
[36] |
Ishida T, Sugamoto Y, Sugita S, et al. Prophylactic vitrectomy for acute retinal necrosis[J]. Jpn J Ophthalmol, 2009, 53(5): 486-489.
|
[37] |
Matsuo T. Timing of prophylactic and early vitrectomy for first-presenting or recurrent acute retinal necrosis syndrome[J]. Acta Med Okayama, 2012, 66(6): 493-497.
|